Rare variant mutations in pregnancy-associated or peripartum cardiomyopathy.

PubWeight™: 1.67‹?› | Rank: Top 3%

🔗 View Article (PMC 2900861)

Published in Circulation on May 10, 2010

Authors

Ana Morales1, Thomas Painter, Ran Li, Jill D Siegfried, Duanxiang Li, Nadine Norton, Ray E Hershberger

Author Affiliations

1: University of Miami Miller School of Medicine, 1501 NW 10th Ave, Miami, FL 33136, USA. rhershberger@med.miami.edu

Articles citing this

Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies. N Engl J Med (2016) 3.40

Clinical Outcomes for Peripartum Cardiomyopathy in North America: Results of the IPAC Study (Investigations of Pregnancy-Associated Cardiomyopathy). J Am Coll Cardiol (2015) 2.87

Update 2011: clinical and genetic issues in familial dilated cardiomyopathy. J Am Coll Cardiol (2011) 2.02

Clinical and genetic issues in dilated cardiomyopathy: a review for genetics professionals. Genet Med (2010) 1.90

Novel SCN5A mutation in amiodarone-responsive multifocal ventricular ectopy-associated cardiomyopathy. Heart Rhythm (2014) 1.55

Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy. Basic Res Cardiol (2013) 1.20

Peripartum cardiomyopathy: current management and future perspectives. Eur Heart J (2015) 1.09

Peripartum cardiomyopathy: a review. Tex Heart Inst J (2012) 1.06

Genetics of sudden cardiac death syndromes. Curr Opin Cardiol (2011) 1.02

Sex and gender differences in myocarditis and dilated cardiomyopathy. Curr Probl Cardiol (2013) 1.01

The genomic architecture of sporadic heart failure. Circ Res (2011) 0.95

Maternal cardiac metabolism in pregnancy. Cardiovasc Res (2014) 0.94

Myocardial recovery in peripartum cardiomyopathy: prospective comparison with recent onset cardiomyopathy in men and nonperipartum women. J Card Fail (2011) 0.92

Next-generation genome-wide association studies: time to focus on phenotype? Circ Cardiovasc Genet (2011) 0.88

Reversible Cardiomyopathies. Clin Med Insights Cardiol (2015) 0.88

Acute and critically ill peripartum cardiomyopathy and 'bridge to' therapeutic options: a single center experience with intra-aortic balloon pump, extra corporeal membrane oxygenation and continuous-flow left ventricular assist devices. Crit Care (2011) 0.86

Peripartum cardiomyopathy: current state of knowledge, new developments and future directions. Curr Cardiol Rev (2014) 0.85

Birthing the genetics of peripartum cardiomyopathy. Circulation (2010) 0.81

Return of genetic results in the familial dilated cardiomyopathy research project. J Genet Couns (2012) 0.81

Familial dilated cardiomyopathy associated with congenital defects in the setting of a novel VCL mutation (Lys815Arg) in conjunction with a known MYPBC3 variant. Cardiogenetics (2011) 0.80

Impact of Mendelian inheritance in cardiovascular disease. Ann N Y Acad Sci (2010) 0.80

Peripartum cardiomyopathy: a contemporary review. Methodist Debakey Cardiovasc J (2013) 0.80

Peripartum cardiomyopathy: moving towards a more central role of genetics. Curr Cardiol Rev (2013) 0.79

Cellular hyper-excitability caused by mutations that alter the activation process of voltage-gated sodium channels. Front Physiol (2015) 0.78

Peripartum cardiomyopathy and dilated cardiomyopathy: different at heart. Front Physiol (2015) 0.76

Almanac 2011: cardiomyopathies. The national society journals present selected research that has driven recent advances in clinical cardiology. Acta Inform Med (2011) 0.75

Comparison of clinical outcomes in peripartum cardiomyopathy and age-matched dilated cardiomyopathy: A 15-year nationwide population-based study in Asia. Medicine (Baltimore) (2017) 0.75

Article Commentary: Acute Heart Failure: Is it Peripartum Cardiomyopathy or Not? Obstet Med (2013) 0.75

Lactation Is a Risk Factor of Postpartum Heart Failure in Mice with Cardiomyocyte-specific Apelin Receptor (APJ) Overexpression. J Biol Chem (2016) 0.75

At the Heart of the Pregnancy: What Prenatal and Cardiovascular Genetic Counselors Need to Know about Maternal Heart Disease. J Genet Couns (2017) 0.75

Clinical Application of Genetic Testing in Heart Failure. Curr Heart Fail Rep (2017) 0.75

Dilated Cardiomyopathy: Genetic Determinants and Mechanisms. Circ Res (2017) 0.75

Articles cited by this

A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell (2007) 5.85

Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA (2000) 4.51

Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med (2000) 4.30

Natural course of peripartum cardiomyopathy. Circulation (1971) 3.60

Genetic evaluation of cardiomyopathy--a Heart Failure Society of America practice guideline. J Card Fail (2009) 3.54

Clinical and genetic issues in familial dilated cardiomyopathy. J Am Coll Cardiol (2005) 3.42

Peripartum cardiomyopathy. Lancet (2006) 3.30

Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy. Am Heart J (2008) 2.48

Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation (2005) 2.48

Peripartum cardiomyopathy. Circulation (1971) 2.47

Peripartum cardiomyopathy. Am Heart J (1995) 2.30

Coding sequence mutations identified in MYH7, TNNT2, SCN5A, CSRP3, LBD3, and TCAP from 313 patients with familial or idiopathic dilated cardiomyopathy. Clin Transl Sci (2008) 2.17

Distribution and categorization of echocardiographic measurements in relation to reference limits: the Framingham Heart Study: formulation of a height- and sex-specific classification and its prospective validation. Circulation (1997) 2.14

Mutation screening in dilated cardiomyopathy: prominent role of the beta myosin heavy chain gene. Eur Heart J (2005) 2.07

Coding sequence rare variants identified in MYBPC3, MYH6, TPM1, TNNC1, and TNNI3 from 312 patients with familial or idiopathic dilated cardiomyopathy. Circ Cardiovasc Genet (2010) 1.98

Mutations of presenilin genes in dilated cardiomyopathy and heart failure. Am J Hum Genet (2006) 1.63

Mutations in PDLIM3 and MYOZ1 encoding myocyte Z line proteins are infrequently found in idiopathic dilated cardiomyopathy. Mol Genet Metab (2007) 1.60

Novel mutations in sarcomeric protein genes in dilated cardiomyopathy. Biochem Biophys Res Commun (2002) 1.55

Clinical characteristics of 304 kindreds evaluated for familial dilated cardiomyopathy. J Card Fail (2006) 1.53

A modified definition for peripartum cardiomyopathy and prognosis based on echocardiography. Obstet Gynecol (1999) 1.44

Clinical and functional characterization of TNNT2 mutations identified in patients with dilated cardiomyopathy. Circ Cardiovasc Genet (2009) 1.43

The role of sarcomere gene mutations in patients with idiopathic dilated cardiomyopathy. Eur J Hum Genet (2009) 1.15

Familial occurrence of postpartal heart failure. Arch Intern Med (1963) 1.11

Peripartum cardiomyopathy: a comprehensive review. Am J Obstet Gynecol (1998) 1.10

Adverse events in families with hypertrophic or dilated cardiomyopathy and mutations in the MYBPC3 gene. BMC Med Genet (2008) 1.06

Peripartum cardiomyopathy in the Hospital Albert Schweitzer District of Haiti. Am J Obstet Gynecol (2002) 1.02

Familial occurrence of peripartum cardiomyopathy. Am Heart J (1995) 0.99

Peripartum cardiomyopathy: review of the literature. Yonsei Med J (2007) 0.98

Family history: an essential tool for cardiovascular genetic medicine. Congest Heart Fail (2008) 0.97

Mother-daughter peripartum cardiomyopathy. Int J Cardiol (2002) 0.94

Familial dilated cardiomyopathy. Am J Cardiol (1984) 0.82

Peripartum cardiomyopathy (PPCM) in both surrogate and biological mother. Hum Reprod (2005) 0.82

Peripartum maternal cardiomyopathy with idiopathic cardiomyopathy in the offspring. A case report. J Reprod Med (1986) 0.79

Articles by these authors

Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet (2008) 10.52

Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet (2013) 7.44

Comparative genome hybridization suggests a role for NRXN1 and APBA2 in schizophrenia. Hum Mol Genet (2007) 5.28

Support for the involvement of large copy number variants in the pathogenesis of schizophrenia. Hum Mol Genet (2009) 4.52

HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Heart Rhythm (2011) 4.31

Clinical and genetic issues in familial dilated cardiomyopathy. J Am Coll Cardiol (2005) 3.42

Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy. Am J Physiol Heart Circ Physiol (2008) 2.59

HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Europace (2011) 2.54

Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy. Am Heart J (2008) 2.48

Genome-wide studies of copy number variation and exome sequencing identify rare variants in BAG3 as a cause of dilated cardiomyopathy. Am J Hum Genet (2011) 2.38

Coding sequence mutations identified in MYH7, TNNT2, SCN5A, CSRP3, LBD3, and TCAP from 313 patients with familial or idiopathic dilated cardiomyopathy. Clin Transl Sci (2008) 2.17

A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain. Am J Hum Genet (2003) 2.11

Update 2011: clinical and genetic issues in familial dilated cardiomyopathy. J Am Coll Cardiol (2011) 2.02

Coding sequence rare variants identified in MYBPC3, MYH6, TPM1, TNNC1, and TNNI3 from 312 patients with familial or idiopathic dilated cardiomyopathy. Circ Cardiovasc Genet (2010) 1.98

Consensus statement: Palliative and supportive care in advanced heart failure. J Card Fail (2004) 1.95

MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a. J Mol Med (Berl) (2008) 1.93

Clinical and genetic issues in dilated cardiomyopathy: a review for genetics professionals. Genet Med (2010) 1.90

Evaluating pathogenicity of rare variants from dilated cardiomyopathy in the exome era. Circ Cardiovasc Genet (2012) 1.78

Full genome screen for Alzheimer disease: stage II analysis. Am J Med Genet (2002) 1.77

Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Heart Fail (2009) 1.74

Cutting edge: FcR-like 6 is an MHC class II receptor. J Immunol (2010) 1.63

Mutations of presenilin genes in dilated cardiomyopathy and heart failure. Am J Hum Genet (2006) 1.63

No major schizophrenia locus detected on chromosome 1q in a large multicenter sample. Science (2002) 1.57

Clinical characteristics of 304 kindreds evaluated for familial dilated cardiomyopathy. J Card Fail (2006) 1.53

Identification of novel mutations in RBM20 in patients with dilated cardiomyopathy. Clin Transl Sci (2010) 1.52

Fatigue-induced damage in Zr-based bulk metallic glasses. Sci Rep (2013) 1.49

Genomewide linkage scan in schizoaffective disorder: significant evidence for linkage at 1q42 close to DISC1, and suggestive evidence at 22q11 and 19p13. Arch Gen Psychiatry (2005) 1.48

Psychosis susceptibility gene ZNF804A and cognitive performance in schizophrenia. Arch Gen Psychiatry (2010) 1.46

Clinical and functional characterization of TNNT2 mutations identified in patients with dilated cardiomyopathy. Circ Cardiovasc Genet (2009) 1.43

Origin of highly pathogenic porcine reproductive and respiratory syndrome virus, China. Emerg Infect Dis (2010) 1.37

Characterization of Streptococcus suis isolates from the diseased pigs in China between 2003 and 2007. Vet Microbiol (2008) 1.37

Acanthamoeba keratitis: clinical characteristics and management. Ophthalmology (2006) 1.36

Effects of gas supersaturation on lethality and avoidance responses in juvenile rock carp (Procypris rabaudi Tchang). J Zhejiang Univ Sci B (2010) 1.34

Regulation of cell-cell adhesion by Abi/Diaphanous complexes. Mol Cell Biol (2009) 1.33

Exome sequencing and genome-wide linkage analysis in 17 families illustrate the complex contribution of TTN truncating variants to dilated cardiomyopathy. Circ Cardiovasc Genet (2013) 1.30

Genetics and cardiovascular disease: a policy statement from the American Heart Association. Circulation (2012) 1.26

Convergent evidence that oligodendrocyte lineage transcription factor 2 (OLIG2) and interacting genes influence susceptibility to schizophrenia. Proc Natl Acad Sci U S A (2006) 1.25

Growth rate, catalase and superoxide dismutase activities in rock carp (Procypris rabaudi Tchang) exposed to supersaturated total dissolved gas. J Zhejiang Univ Sci B (2011) 1.24

The relative contribution of point mutations and genomic rearrangements in BRCA1 and BRCA2 in high-risk breast cancer families. Cancer Res (2008) 1.24

Genome screen for loci influencing age at onset and rate of decline in late onset Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet (2005) 1.22

Regulation of Akt/FOXO3a/GSK-3beta/AR signaling network by isoflavone in prostate cancer cells. J Biol Chem (2008) 1.20

Variation at the DAOA/G30 locus influences susceptibility to major mood episodes but not psychosis in schizophrenia and bipolar disorder. Arch Gen Psychiatry (2006) 1.19

Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia: interactions with tobacco and cannabis use. Br J Psychiatry (2007) 1.19

Streamlined analysis of pooled genotype data in SNP-based association studies. Genet Epidemiol (2005) 1.18

Research priorities in hypertrophic cardiomyopathy: report of a Working Group of the National Heart, Lung, and Blood Institute. Circulation (2010) 1.18

Reconsidering association testing methods using single-variant test statistics as alternatives to pooling tests for sequence data with rare variants. PLoS One (2012) 1.17

Combination of fluid and solid mechanical stresses contribute to cell death and detachment in a microfluidic alveolar model. Lab Chip (2010) 1.11

Single dopaminergic neurons that modulate aggression in Drosophila. Proc Natl Acad Sci U S A (2013) 1.10

Support for RGS4 as a susceptibility gene for schizophrenia. Biol Psychiatry (2004) 1.10

Distribution of bacterial keratitis and emerging resistance to antibiotics in China from 2001 to 2004. Clin Ophthalmol (2008) 1.08

Association analysis of monoamine oxidase A and attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet (2003) 1.08

Strong evidence that GNB1L is associated with schizophrenia. Hum Mol Genet (2007) 1.07

SCN5A rare variants in familial dilated cardiomyopathy decrease peak sodium current depending on the common polymorphism H558R and common splice variant Q1077del. Clin Transl Sci (2010) 1.07

Gene copy number variation in schizophrenia. Schizophr Res (2007) 1.06

Infectious keratitis related to orthokeratology. Ophthalmic Physiol Opt (2006) 1.05

Genome-wide association study of multiplex schizophrenia pedigrees. Am J Psychiatry (2012) 1.05

Acute decompensated heart failure: update on new and emerging evidence and directions for future research. J Card Fail (2013) 1.04

Gene expression profiling revealed novel mechanism of action of Taxotere and Furtulon in prostate cancer cells. BMC Cancer (2005) 1.04

Convergent evidence for 2',3'-cyclic nucleotide 3'-phosphodiesterase as a possible susceptibility gene for schizophrenia. Arch Gen Psychiatry (2006) 1.04

Variation in the protocadherin gamma A gene cluster. Genomics (2003) 1.03

Microbiological analysis of chronic dacryocystitis. Ophthalmic Physiol Opt (2005) 1.03

Polymorphisms in the MAOA, MAOB, and COMT genes and aggressive behavior in schizophrenia. Am J Med Genet B Neuropsychiatr Genet (2004) 1.03

Indications for cardiac resynchronization therapy: 2011 update from the Heart Failure Society of America Guideline Committee. J Card Fail (2012) 1.02

The carcinogenic liver fluke, Clonorchis sinensis: new assembly, reannotation and analysis of the genome and characterization of tissue transcriptomes. PLoS One (2013) 1.02

Genetics and genomics for the prevention and treatment of cardiovascular disease: update: a scientific statement from the American Heart Association. Circulation (2013) 1.01

Update on aldosterone antagonists use in heart failure with reduced left ventricular ejection fraction. Heart Failure Society of America Guidelines Committee. J Card Fail (2012) 1.00

Evaluation of a susceptibility gene for schizophrenia: genotype based meta-analysis of RGS4 polymorphisms from thirteen independent samples. Biol Psychiatry (2006) 1.00

Multiple indicator hidden Markov model with an application to medical utilization data. Stat Med (2009) 1.00

No association between schizophrenia and polymorphisms in COMT in two large samples. Am J Psychiatry (2005) 1.00

Common susceptibility variants examined for association with dilated cardiomyopathy. Ann Hum Genet (2010) 0.99

Australian carybdeid jellyfish causing "Irukandji syndrome". Toxicon (2012) 0.98

miR-26b promotes granulosa cell apoptosis by targeting ATM during follicular atresia in porcine ovary. PLoS One (2012) 0.98

Lophomonas blattarum Infection or Just the Movement of Ciliated Epithelial Cells? Chin Med J (Engl) (2016) 0.98

Cardiac troponin T lysine 210 deletion in a family with dilated cardiomyopathy. J Card Fail (2002) 0.98

A new Tn1546 type of VanB phenotype-vanA genotype vancomycin-resistant Enterococcus faecium isolates in mainland China. Diagn Microbiol Infect Dis (2009) 0.97

Family history: an essential tool for cardiovascular genetic medicine. Congest Heart Fail (2008) 0.97

Identification and characterization of a novel protective antigen, Enolase of Streptococcus suis serotype 2. Vaccine (2009) 0.97

Microfluidic platforms for mechanobiology. Lab Chip (2013) 0.97

Disturbance of the OPG/RANK/RANKL pathway and systemic inflammation in COPD patients with emphysema and osteoporosis. Respir Res (2011) 0.96

Morphological analysis of 13 LMNA variants identified in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy. Circ Cardiovasc Genet (2009) 0.96

Genetic testing in cardiovascular medicine: current landscape and future horizons. Curr Opin Cardiol (2013) 0.96

Macromolecular crowding directs extracellular matrix organization and mesenchymal stem cell behavior. PLoS One (2012) 0.95

Gene expression profiling revealed novel molecular targets of docetaxel and estramustine combination treatment in prostate cancer cells. Mol Cancer Ther (2005) 0.95

Next-generation sequencing to identify genetic causes of cardiomyopathies. Curr Opin Cardiol (2012) 0.95

Ocular nocardiosis: HSP65 gene sequencing for species identification of Nocardia spp. Am J Ophthalmol (2007) 0.95